Logo
Foto von Roberts ZĪLE
Member:
Country: Latvia
Group: (ECR) European Conservatives and Reformists (ECR) European Conservatives and Reformists (ECR) Logo
Debate contributions: 132
Voting Pattern

EU Parliament Votes of

Foto von Roberts ZĪLE
Country: Latvia
Group: (ECR) European Conservatives and Reformists (ECR) European Conservatives and Reformists (ECR) Logo
Debate contributions: 132
Voting Pattern: Total: 0
10.10.2019
The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
My vote: For
426
Against
208
Abstention
20
Did not vote
97

Reference: B9-0105/2019

10.10.2019
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MZHG0JG (SYN-ØØØJG-2), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
My vote: For
436
Against
208
Abstention
16
Did not vote
91

Reference: B9-0107/2019

10.10.2019
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron
For
417
Against
200
My vote: Abstention
40
Did not vote
94

Reference: B9-0104/2019

10.10.2019
Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole
For
402
Against
222
My vote: Abstention
39
Did not vote
88

Reference: B9-0103/2019

10.10.2019
Flexibility Instrument: adjustments to the amounts mobilised for 2019 to be used for migration, refugee inflows and security threats
For
53
My vote: Against
526
Abstention
82
Did not vote
90

Reference: A9-0013/2019

10.10.2019
Amending budget 4/2019: reduction of commitment and payment appropriations in line with updated needs of expenditure and update of revenue (own resources)
My vote: For
538
Against
113
Abstention
9
Did not vote
91

Reference: A9-0012/2019

19.09.2019
The state of implementation of the Union’s anti-money laundering legislation
My vote: For
530
Against
14
Abstention
104
Did not vote
103

Reference: B9-0045/2019

19.09.2019
The importance of European remembrance for the future of Europe
My vote: For
535
Against
66
Abstention
52
Did not vote
98

Reference: RC-B9-0097/2019

19.09.2019 Iran
Iran, notably the situation of women’s rights defenders and imprisoned EU dual nationals
My vote: For
608
Against
7
Abstention
46
Did not vote
90

Reference: RC-B9-0089/2019

18.09.2019 United Kingdom
The state of play of the UK’s withdrawal from the European Union
For
544
My vote: Against
126
Abstention
38
Did not vote
43

Reference: B9-0038/2019

18.09.2019
Amending budget 2/2019: Horizon 2020 and Erasmus+
My vote: For
614
Against
69
Abstention
10
Did not vote
58

Reference: A9-0004/2019

18.07.2019 Venezuela
The situation in Venezuela
For
455
Against
85
Abstention
105
My vote: Did not vote
106

Reference: RC-B9-0006/2019

Showing 12 of 2082